Functional implications of neuropsychological normality and symptom remission in older outpatients diagnosed with schizophrenia: A cross-sectional study

被引:82
作者
Leung, Winnie W. [1 ,2 ]
Bowie, Christopher R. [2 ,3 ]
Harvey, Philip D. [2 ,4 ]
机构
[1] VISN Mental Illness Res Educ & Clin Ctr MIRECC 3, Dept Vet Affairs, Bronx, NY USA
[2] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA
[3] James J Peters Bronx VA Med Ctr, Bronx, NY USA
[4] Emory Univ, Sch Med, Dept Psychiat, Atlanta, GA 30322 USA
关键词
cognition; normal range; outcome; adjustment; social behavior; independent living;
D O I
10.1017/S1355617708080600
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Cognitive impairments in schizophrenia are well documented and correlated with functional disability. Although some patients demonstrate normal neuropsychological (NP) functioning, little is known about their functional disability. We examined the cross-sectional functional implications of NP normality and symptomatic remission in older Outpatients diagnosed with schizophrenia or schizoaffective disorder, who were administered a NP battery and performance-based measures Of functional and social competence, with their real-world functioning rated by case managers. NP status was classified by the General Deficit Score (GDS) and remission status was based on the Positive and Negative Syndrome Scale (PANSS), yielding four subsamples of patients: NP normal-remitted (n = 21), NP normal-symptomatic (n = 22), NP impaired-remitted (n = 90), and NP impaired-symptomatic (n = 97). NP normal patients demonstrated better functional and social competence and better ratings of real world functioning, after controlling for premorbid abilities. However, compared to normative date, NP normal patients manifested disability in several real-world domains, including residential status. These results suggest that NP status is a better predictor of functional outcome then symptom status or the interaction of the two factors. The disability seen in NP normal cases indicates that factors other than cognitive impairments may determine aspects of everyday outcomes in schizophrenia.
引用
收藏
页码:479 / 488
页数:10
相关论文
共 61 条
[31]  
Heaton R K, 1995, J Int Neuropsychol Soc, V1, P231
[32]   Cognitive enhancement therapy for schizophrenia - Effects of a 2-year randomized trial on cognition and behavior [J].
Hogarty, GE ;
Flesher, S ;
Ulrich, R ;
Carter, M ;
Greenwald, D ;
Pogue-Geile, M ;
Kechavan, M ;
Cooley, S ;
DiBarry, AL ;
Garrett, A ;
Parepally, H ;
Zoretich, R .
ARCHIVES OF GENERAL PSYCHIATRY, 2004, 61 (09) :866-876
[33]  
Jastak S., 1994, WIDE RANGE ACHIEVEME
[34]   THE POSITIVE AND NEGATIVE SYNDROME SCALE (PANSS) FOR SCHIZOPHRENIA [J].
KAY, SR ;
FISZBEIN, A ;
OPLER, LA .
SCHIZOPHRENIA BULLETIN, 1987, 13 (02) :261-276
[35]  
Keefe RSE, 1996, AM J PSYCHIAT, V153, P806
[36]   Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: A randomized, double-blind trial of olanzapine versus low doses of haloperidol [J].
Keefe, RSE ;
Seidman, LJ ;
Christensen, BK ;
Hamer, RM ;
Sharma, T ;
Sitskoorn, MM ;
Lewine, RRJ ;
Yurgelun-Todd, DA ;
Gur, RC ;
Tohen, M ;
Tollefson, GD ;
Sanger, TM ;
Lieberman, JA .
AMERICAN JOURNAL OF PSYCHIATRY, 2004, 161 (06) :985-995
[37]  
KOREN D, 2006, CURRENT PSYCHIAT REV, V2, P198
[38]   The paradox of normal neuropsychological function in schizophrenia [J].
Kremen, WS ;
Seidman, LJ ;
Faraone, SV ;
Toomey, R ;
Tsuang, MT .
JOURNAL OF ABNORMAL PSYCHOLOGY, 2000, 109 (04) :743-752
[39]   Measurement and Treatment Research to Improve Cognition in Schizophrenia: NIMH MATRICS initiative to support the development of agents for improving cognition in schizophrenia [J].
Marder, SR ;
Fenton, W .
SCHIZOPHRENIA RESEARCH, 2004, 72 (01) :5-9
[40]   Development of a brief scale of everyday functioning in persons with serious mental illness [J].
Mausbach, Brent T. ;
Harvey, Phillip D. ;
Goldman, Sherry R. ;
Jeste, Dilip V. ;
Patterson, Thomas L. .
SCHIZOPHRENIA BULLETIN, 2007, 33 (06) :1364-1372